rosoxacin
A quinolinemonocarboxylic acid that is 1,4-dihydroquinoline-3-carboxylic acid that is substituted by an ethyl group at position 1 and by a pyridin-4-yl group at position 7. An antibacterial drug, active against Neisseria gonorrhoeae, it has been used for treating urinary tract infections and certain sexually transmitted diseases.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
Classification
-
CHEBI:26421 -
CHEBI:26512 - quinolone antibiotic
CHEBI:86324
Chemical structure
| Molecular formula | C17H14N2O3 |
|---|---|
| Charge | 0 |
| Average mass | 294.31 Da |
| Monoisotopic mass | 294.10044 Da |
| Source | ChEBI |
| InChIKey | XBPZXDSZHPDXQU-UHFFFAOYSA-N |
CCn1cc(C(=O)O)c(=O)c2ccc(-c3ccncc3)cc21
InChI=1S/C17H14N2O3/c1-2-19-10-14(17(21)22)16(20)13-4-3-12(9-15(13)19)11-5-7-18-8-6-11/h3-10H,2H2,1H3,(H,21,22)
Also called
- Eradacil
- rosoxacina
- rosoxacine
- rosoxacinum
- 1-ethyl-4-oxo-7-(pyridin-4-yl)-1,4-dihydroquinoline-3-carboxylic acid
- 1-ethyl-1,4-dihydro-4-oxo-7-(4-pyridyl)-3-quinolinecarboxylic acid
- Win 35,213
- Win 35213
- Win-35,213
Cross-references
- cas:40034-42-2
- hmdb:HMDB0014955
- reaxys:758231
Drug registries
Patents and articles
Activity roles
- antimicrobial agent
CHEBI:33281 - antibacterial drug
CHEBI:36047
Source concepts
| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| CHEBI | CHEBI:131715 |
rosoxacin | antibioticmech:chebi-07bcff1ed1 |
2026-08-30 |
Curation history
-
SEEDED_FROM_SOURCES
Seeded from data/raw/ inventories (CHEBI)
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories
-
RESEEDED_FROM_SOURCES
Re-seeded from updated data/raw/ inventories